Published: 2017-01-10

Investigating the geographical distribution of skin cancer (BCC type) in Ardabil province via GIS

Alireza Mohebbipour, Saeid Alipour, Saeid Sadeghiyeh Ahari, Firouz Amani, Esmaeil Farzaneh


Background: Skin cancer is the most common type of cancer in most countries and it holds the first or the second place in terms of frequency in different areas of the country. BCC is the most usual type of tumor in the white skinned people, and its incidence rate rises as individuals get older, especially after age 40.Thistype of skin cancer mostly occurs in the white skinned people and, in85% of cases; it develops on the head and neck. This study aimed at examining the geographical distribution of skin cancer (BCC type) in Ardabil province through GIS.

Methods: This cross-sectional study has been done on 131 cases of skin cancer with type BCC in 2007-2014. The required information such as age, sex, occupation, and the locus of BCC, was extracted from the patients' records based on their place of residence. Data analysis was performed using SPSS (version 20). ARC GIS (version 10) was used for drawing geographic maps.

Results: 50.4% of the subjects were men and the mean age of them was 62.8±14.5 years. Of the subjects, 66.4% were from Ardabil city, 80.2% from urban population and 15.3% of the subjects were smokers. Of the patients, 78.5% had developed cancer in their face.

Conclusions: Results showed that for control of cancer, educational interventions should be given priority, and people should be instructed about the use of personal protection equipment, like proper sunscreen cream, hat and sunshade in the workplace, as far as it is possible.



Cancer, Geographical distribution, BCC, GIS, Ardabil

Full Text:



Marjani A, Kabir MJ. Male skin cancer incidence in Golestan province, Iran. J Pak Med Assoc. 2009;59(5):287-9.

Afzali M, Mirzaei M, Saadati H, Mazloomi-Mahmood-Abadi S. Epidemiology of skin cancer and changes in its trends in Iran. KAUMS Journal (FEYZ). 2013;17(5):501-11.

Kim RH, Armstrong AW. No melanoma skin cancer. Dermatol Clin. 2011;30:125-39.

Taylor SR. “Sun Smart Plus”: the more informed use of sunscreens. Med J Aust. 2004;180:36-7.

Koosha A, Farahbakhsh M, Hakimi S, Abdolahi L, Golzari M, Seyf Farshad M. Epidemiologic assessment of cancer disease in east Azerbaijan 2007. Med J Tabriz Univ Med Sci. 2010;32:74-9.

Guy GP, Ekwueme DU. Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature. Pharmacoeconomics. 2011;29:863-74.

Leiter U, Garbe C. Epidemiology of melanoma and no melanoma skin cancer--the role of sunlight. Adv Exp Med Biol. 2008;624:89-103.

Nabizadeh R, Salehi S, Younesian M, Naddafi K. Evaluation of the relationship between global ultraviolet index in different regions of Iran and skin cancer in 1383. Iran J Environ Health. 2010;2:258-67.

Greinert R, Boniol M. Skin cancer-Primary and secondary prevention (information campaigns and screening)-With a focus on children & sunbeds. Prog Biophys Mol Biol. 2011;107:473-6.

Shariatzadeh SMA, Hamta A, Soleimani Mehranjani M, Rasooli Z. Determination of chromosomal changes in DMBA-induced skin cancer in SD rat strains. J Arak Univ Med Sci. 2009;12(2):73-87.

Mahmoodabad SS, Noorbala MT, Mohammadi M, Rahaei Z, Ehrampush MH. Knowledge, attitude, and performance of students toward skin cancer in Yazd, 2009. Int J Dermatol. 2011;50(10):1262-5.

Talaiezadeh A, Tabesh H, Sattari A, Ebrahimi S. Cancer incidence in southwest of Iran: first report from Khuzestan population-based cancer registry, 2002-2009. Asian Pac J Cancer Prev. 2013;14(12):7517-22.

Valavi E, Rafie S, Pakseresht P, Siadat S. Prevalence of skin cancer in southwest of Iran. Koomesh. 2013;15(1):83-8.

Yazdanfar A, Ghasemi E. Frequency of skin cancers in Hamedan from 1991 to 2007. Dermatology and Cosmetic.2011;2:115-23.

Noorbala MT, Kafaie P. Analysis of 15 years of skin cancer in central Iran (Yazd). Dermatol Online J. 2007 Oct 13;13(4):1-6.

Pirzadeh A, Setoudeh M, Ghader B. Study prevalence of skin tumors in patients hospitalized in Fatemi Hospital in last five years. Medical Doctora Thesis (unpublished). Available from: (in Persian).

William FA, William CH, Charles RK. Changes in non-melanoma skin cancer incidence between 1977 -1999 in North central New Mexico. Cancer Epidemiology Biomarkers & Prevention. 2003;12:1105-8.

Robati RM, Toossi P, Karimi M, Ayatollahi A, Esmaeli M. Screening for skin cancer: a pilot study in Tehran, Iran. Indian J Dermatol. 2014;59(1):105-10.

Stang A, Stegmaier C, Jockel K. Non melanoma skin cancer in the Federal state of Saarland, Germany, 1995-1999. British Journal of cancer. 2003;89:1205-8.

Amouzgar MH, Yazdanpanah MJ, Ebrahimirad M. Frequency of different skin cancer in Qaem hospital of Mashhad, from 1975-1995: A cross-sectional study. Iran J Dermatol. 2006;19:28-34.

Wallberg P, Skog E. The increasing incidence of basal cell carcinoma.Br J Dermatol. 1994;131:914-5.

Grossman D, Leffell D. Squamous cell carcinoma. In: Wolff K, Goldsmith S, Katz S, Gilchrest B, Paller A, Leffell D. Fitzpatrick's dermatology in general medicine. 7th Ed. NewYork: McGraw-Hill, 2008. pp. 1028-36.

Coolins GL, Nickoonahand N, Morgan MB. Changing demographics and pathology of non-melanoma skin cancer in the last 30 years. Semin Cutan Med Surg. 2004;23:80-3.

Farahand M, Almasi-Hashiani A, Hassanzade J, Moghadami M. Childhood cancer Epidemiology based on cancer registry’s data of Fars province of Iran. Koomesh. 2011;13:8-13.

Abedipour M. Survey of a-10 year incidence of non-melanoma skin cancer in Iran, A clinicopathological study. Acta Medica Iranica. 1995;33:96-9.

Kavoussi H, Rezaei M, Ebrahimi A, Hosseini S. Epidemiological indices of non-melanoma skin cancers in Kermanshah, Iran. J Pak Assoc. 2012;22:112-7.